In a 3-year follow-up study after resection of the primary tumour, the preoperative methylated levels of RUNX3 of 52 patients with recurrence were significantly higher than that of 292 patients without recurrence (P = 0.0003) [22]. Here, RUNX3 is linked to neoplasm.